What is the impact of medical research conducted by Chinese hospitals in the past 20 years? At the 2025 China International Fair for Trade in Services, the renowned international journal British Medical Journal released the "2025 China Hospital Research Influence Report", revealing the quantifiable impact of Chinese medical research on global medical clinical diagnosis and public health decision-making, injecting Eastern wisdom into human health. The report points out that between 2005 and 2024, the top ten Chinese hospitals with the highest number of cited articles published a total of over 12000 articles that were cited in global health policies and clinical guidelines documents, with a total of nearly 35000 citations in health policies and clinical guidelines from over 75 countries worldwide. At the opening ceremony of the 2025 Capital International Medical Conference. The report focuses on the top ten Chinese hospitals with the highest number of cited articles, including West China Hospital of Sichuan University, Peking Union Medical College Hospital, the First Affiliated Hospital of Sun Yat sen University, and Peking University First Hospital. ”Kong Yuyan, the head of the China region of the British Medical Journal Group, introduced. The report points out that Chinese medical research is playing an increasingly important role in shaping international medical standards, improving medical service supply, and enhancing global patient treatment outcomes... Behind this data, it reflects the efforts of the Chinese medical community to enhance the visibility of research, especially in improving the influence of widely accessible clinical guidelines and policies, enabling academic discoveries to be better translated into actionable medical practices, supporting treatment standardization, and improving patient outcomes. Intensive care saves patients from the brink of death, and sepsis is one of the biggest risk challenges. The team led by Du Bin, founder of the Internal Medicine ICU Department at Peking Union Medical College Hospital, overcame numerous difficulties such as the lack of epidemiological data on sepsis in middle-income countries and established a multi center cohort to study disease burden from different dimensions, enriching epidemiological data. In 2021, he was invited as the first Chinese scholar to participate in the development of international clinical guidelines for sepsis. Always write papers on the front line of clinical practice. In 2020, the team led by Cui Guoqing from the Institute of Sports Medicine at Peking University Third Hospital pioneered the use of lifting resistance test and abduction external rotation resistance test, which were included in the guidelines of the American Orthopaedic Association as "high-quality research" and actively promoted and popularized. The high-quality 'Chinese solution' is expected to improve the treatment effectiveness of a wider range of patients - the report points out that Chinese hospitals are gradually producing more and more high-quality research, making important contributions to promoting global medical progress, especially in fields such as oncology, cardiology, and infectious diseases. Taking bone marrow transplantation as an example, the scarcity of donor sources was once a global problem. In February 2024, Huang Xiaojun, an academician of the CAE Member and director of the Institute of Hematology of Peking University, won the Outstanding Service Award issued by the International Research Center for Blood and Bone Marrow Transplantation for his creation of the "Beijing Program" - non in vitro T cell depleted haplotype compatible transplantation technology, bringing hope to patients with blood cancer worldwide. Tu Youyou, chief researcher of the Chinese Academy of Traditional Chinese Medicine and winner of the Nobel Prize in Physiology or Medicine, started researching ancient Chinese medical texts and screened for the anti malaria effective ether neutral extract of the traditional Chinese medicine Artemisia annua. With the "Chinese Grass" and "Chinese Solution", she saved the lives of millions of malaria patients worldwide. Showcasing the unique charm and profound heritage of traditional Chinese medicine to the world. As an important part of the Health and Health Services Special Session of the Service Trade Fair, the 3rd Traditional Chinese Medicine Conference of Beijing Tongrentang was held here, with more than 1300 expert representatives from the traditional Chinese medicine community discussing the integration of traditional Chinese medicine and modern technology; The "Intelligent and Quantitative Analysis Technology and System for Traditional Chinese and Western Medicine Based on Network Targets" independently developed by Professor Li Shao's team at Tsinghua University strives to "explain and clarify" the mechanism of action of traditional Chinese medicine... Classics are the root, clinical practice is the blade, and technology is the driving force. Chinese traditional medicine industry, academia, research, and application are working together to spread the wisdom of Eastern health even further. On the road to health, strive to ensure that no group falls behind. Ni Xin, the director of the National Children's Medical Center and Beijing Children's Hospital, led a team to conduct a phase III clinical trial of the innovative anti respiratory syncytial virus drug Ziresovir, which was selected for the WHO Children's Drug Priority List in 2025, demonstrating the responsibility and strength of Chinese scholars in the development of new drugs for children. The latest data released by the National Health Commission shows that the proportion of new drugs under development in China exceeds 20% of the global total, ranking second in global new drug research and development. Focusing on "future healthcare", exploring the integration of medical engineering and digital intelligence upgrading - AI pediatricians, 5G remote surgical robots, intelligent fundus cameras, brain computer interfaces... Walking into the 2025 Service Trade Fair Health and Health Service Special Exhibition located in Hall 2 of Beijing Shougang Park, Chinese digital medical products from the integration of medical engineering make people eagerly look forward to the "future hospital". Zhao Guoguang from Xuanwu Hospital of Capital Medical University led a team to complete the world's first clinical exploration of epidural brain computer interface treatment for cervical spinal cord injury in October 2023. Mr. Yang, 54 years old, has been paralyzed in all four limbs for 14 years due to a car accident. Three months after the surgery, he successfully completed the "drinking water with intention" and "grasping" movements using a brain computer interface assisted exoskeleton. This research achievement is expected to obtain a Class III medical device registration certificate for brain computer interfaces next year. A batch of innovative achievements such as brain computer interfaces, nanomedicine delivery, and adaptive adjustment of artificial intelligence demonstrate that China's medical research is advancing towards a more complete system, advanced technology, and distinctive frontier exploration. Everyone enjoys health, which is the common vision of all mankind and an important part of building a community with a shared future for mankind. ”Lei Haichao, Director of the National Health Commission, said that the Chinese government has been vigorously promoting medical technology research and development, concentrating efforts on tackling common challenges facing human health. I hope that countries around the world can further expand the network of communication and cooperation, promote the transformation and sharing of medical technology achievements on a wider scale, and benefit patients worldwide. (New Society)